DBCCF (DBCCF) Stock Price & Analysis
DBCCF (DBCCF) rose 0.65% to USD 0.08 as of July 25, 2026 at 10:04 UTC, according to Nexqual real-time market data.
DBCCF last closed at USD 0.08; the session ranged USD 0.08–0.08 on volume of 500,000 shares. Market capitalization is $45.01M, with a 52-week range of USD 0.06–0.11 (OQB). Source: Nexqual, July 25, 2026 at 10:04 UTC.
Key Statistics (as of July 25, 2026 at 10:04 UTC)
| Price | USD 0.08 |
|---|---|
| Change | ▲ 0.65% (up) |
| Previous Close | USD 0.08 |
| Open | USD 0.08 |
| Day Range | USD 0.08 – 0.08 |
| 52-Week Range | USD 0.06 – 0.11 |
| Volume | 500,000 shares |
| Market Cap | $45.01M |
| Exchange | OQB |
Technical Analysis (DBCCF)
Nexqual's technical model rates DBCCF "SELL" based on 2 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 10:04 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 43.14 (neutral) |
| vs SMA50 | Below (USD 0.08) |
| MACD | -0 (negative) |
Analyst Ratings (DBCCF)
Wall Street analysts rate DBCCF "None", per Nexqual as of July 25, 2026 at 10:04 UTC.
| Consensus Rating | None |
|---|
Earnings (DBCCF)
| Next Earnings Date | 2026-08-20 |
|---|---|
| Revenue Estimate | $33.88M |
Source: Nexqual, July 25, 2026 at 10:04 UTC.
Financials & Fundamentals (DBCCF)
| Total Revenue | $121.32M |
|---|---|
| Revenue Growth (YoY) | +40.50% |
| Gross Margin | +38.39% |
| Operating Margin | +9.55% |
| Profit Margin | -2.64% |
| ROE | -5.19% |
| Debt / Equity | 96.13 |
| Current Ratio | 2.76 |
| Total Cash | $5.99M |
| Total Debt | $57.98M |
| Free Cash Flow | $-10.71M |
Source: Nexqual, July 25, 2026 at 10:04 UTC.
Financial Health Score (DBCCF)
Nexqual rates DBCCF's overall financial health "Mixed" across five dimensions, as of July 25, 2026 at 10:04 UTC.
| Growth | Strong — Revenue +22% YoY (annual) |
|---|---|
| Profitability | Solid — Gross margin 38%, operating 10% |
| Balance Sheet | Mixed — $6M cash vs $58M debt |
| Cash Flow | Weak — FCF negative: -$11M, burning cash |
| Efficiency | Critical — ROE -5%, ROA 1.5% |
Ownership (DBCCF)
| Insider Ownership | +24.24% |
|---|---|
| Institutional Ownership | +0.00% |
| Shares Outstanding | 577.04M |
| Float | 428.16M |
Source: Nexqual, July 25, 2026 at 10:04 UTC.
Leadership (DBCCF)
DBCCF is led by Benjamin Sze (age 42), CEO & Director, per Nexqual as of July 25, 2026 at 10:04 UTC.
| CEO & Director | Benjamin Sze (age 42) |
|---|---|
| Chief Financial Officer | Stuart Boucher |
| Chief Revenue Officer | Adam Coates (age 37) |
| Chief Operating Officer | Kris Newell |
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ROMJF | Rubicon Organics Inc. | USD 0.34 | ▲ 4.36% |
| AVCNF | Avicanna Inc. | USD 0.1 | ▼ 0.99% |
| LOVFF | Cannara Biotech Inc. | USD 1.35 | ▲ 3.85% |
| VEXTF | Vext Science Inc. | USD 0.17 | ▲ 1.08% |
| BMMJ | Body and Mind Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 10:04 UTC. This page is informational and not investment advice.